Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis

Thrombosis and Haemostasis

Volumn 103, Issue 2, 2010, Pages 408-414

  Panzer, Simon ^a   Eslam, Roza Badr ^a   Schneller, Alexandra ^a   Kaider, Alexandra ^a   Koren, Daniela ^a   Eichelberger, Beate ^a   Rosenhek, Raphael ^a   Budde, Ulrich ^b   Lang, Irene M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Aesculabor Hamburg GmbH   (Germany)

Author keywords

Aortic stenosis; Platelet adhesion; Platelet aggregation; Von willebrand multimers

Indexed keywords

ADENOSINE DIPHOSPHATE; PADGEM PROTEIN; POLYMER; VON WILLEBRAND FACTOR;

ADULT; AGED; AORTA DISEASE; AORTA STENOSIS; AORTA SURGERY; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; PROTEIN MULTIMERIZATION; VON WILLEBRAND FACTOR;

EID: 75749105466     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-06-0391     Document Type: Article

References (24)

1. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med 1958; 259: 196.
2. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 1992; 340: 35-37.
3. Tsai HM, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994; 83: 2171-2179.
4. Tsai HM. Shear stress and von Willebrand factor in health and disease. Semin Thromb Hemost 2003; 29: 479-488.
5. Anderson RP, McGrath K, Street A. Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement. Lancet 1996; 347: 689-690.
6. Warkentin TE, Moore JC, Morgan DG. Gastrointestinal angiodysplasia and aortic stenosis. N Engl J Med 2002; 347: 858-859.
7. Veyradier A, Balian A, Wolf M, et al. Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. Gastroenterology 2001; 120: 346-353.
8. Pareti FI, Lattuada A, Bressi C, et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000; 102: 1290-1295.
9. Vincentelli A, Susen S, Le TT, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-349.
10. Yoshida K, Tobe S, Kawata M. Acquired von Willebrand disease type IIA in patients with aortic valve stenosis. Ann Thorac Surg 2006; 81: 1114-1116.
11. Sucker C. The Heyde syndrome: proposal for a unifying concept explaining the association of aortic valve stenosis, gastrointestinal angiodysplasia and bleeding. Int J Cardiol 2007; 115: 77-78.
12. Warkentin TE, Moore JC, Anand SS, et al.Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003; 17: 272-286.
13. Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008; 33: 679-684.
14. Reininger AJ, Heijnen HF, Schumann H, et al. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006; 107: 3537-3545.
15. Ruggeri ZM, Orje JN, Habermann R, et al. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006; 108: 1903-1910.
16. Budde U, Schneppenheim R, Plendl H, et al. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990; 63: 312-315.
17. Budde U, Pieconka A, Will K, et al. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification. Semin Thromb Hemost 2006; 32: 514-521.
18. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-163.
19. Shenkman B, Einav Y, Salomon O, et al. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]. Platelets 2008; 19: 440-446.
20. Panzer S, Höcker L, Koren D. Agonists-induced platelet activation varies considerably in healthy male individuals studies by flow cytometry. Ann Hematol 2006 85: 121-125.
21. Revel-Vilk S, Hyam E, Zelikowitz T, et al. Evaluation of Children with Suspected Bleeding Disorder Applying the Impact-R [Cone and Plate(let) Analyzer]. ASH Annual Meeting Abstracts 2007; 110: 3962.
22. Sucker C, Feindt P, Scharf RE. Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med 2003; 349: 1773.
23. Schmid W, Steindl-Munda Petra , Mandl C, et al. Estimation of platelet function under high shear conditions to assist a rapid diagnosis of Heyde Syndrome. Platelets 2008; 19: 636-640.
24. Panzer S, Eichelberger B, Koren D, et al. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R). Transfusion 2007; 47: 103-106.